InvestorNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Joins NYSE-Listed Cannabis ETF

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a Canadian biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, has been added to the Cannabis ETF (NYSE: THCX), an exchange-traded fund that trades on NYSE Arca. Listed on NYSE Arca, THCX tracks the Innovation Labs Cannabis Index, which is a portfolio of 33 stocks that are expected to benefit from the growth of the legal global marijuana, cannabidiol (“CBD”) and hemp industries. THCX is expanding to include a variety of cannabis industry subthemes, which now includes Willow’s industry-leading manufacturing capabilities that produce ultra-pure, sustainably produced cannabinoids created with a fraction of the environmental footprint that traditional plant cultivation yields. The addition of Willow to the index is intended to appeal to investors looking to participate in the next generation of cannabinoid manufacturing. “As the only publicly traded, pure-play company that is biosynthetically producing cannabinoids, inclusion in THCX will allow us to reach a much broader group of investors looking to capture the large, global, total addressable market Willow is targeting,” said Willow president and CEO Trevor Peters in the press release. “As we have just commenced the commercialization stage of our first cannabinoid, cannabigerol, this milestone comes at the perfect time as we are transitioning into a revenue-generating company.”

To view the full press release, visit https://ibn.fm/GVnCB

About Willow Biosciences Inc.

Willow Biosciences is a Canadian biotechnology company based in Vancouver, British Columbia, that develops and produces high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Willow’s manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers. Willow’s team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries. For more information about the company, visit www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.